GENSYGenus Plc
Price Chart
Loading chart...
About Genus Plc (GENSY)
Genus Plc (GENSY) is a Biotechnology company headquartered in Basingstoke, United Kingdom whose shares trade over-the-counter on the Pink tier.
Genus is an animal genetics company. Co. breeds pigs and cattle, so farmers can produce meat and milk. Co. selects animals with characteristics that include feed, disease resistance, growth rate, protein and fat content, and fertility. Co. operates through three segments: Genus PIC, which sells sows, boars and semen, to breed pigs with desirable characteristics for pork production; Genus ABS, which sells bull semen and embryos, which are delivered through artificial insemination to breed calves with desirable characteristics for milk and beef production; and Research and development, which identifies genetically superior bulls in several breeds, primarily the Holstein dairy breed.
GENSY key facts
- Ticker symbol
- GENSY
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Basingstoke, United Kingdom
- Country of incorporation
- GB
- Estimated market cap
- $1.59B (as of May 12, 2025)
- Shares outstanding
- 65,395,000
- Reporting standard
- International Reporting: LSE - London Stock Exchange
- Audit status
- Not Available
- Fiscal year end
- 6/30
Genus Plc leadership
- Richard Wood — CEO
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with G
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Genus Plc (GENSY) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...